Trilogy Capital
RODM icon

Trilogy Capital’s Hartford Multifactor Developed Markets ex-US ETF RODM Stock Holding History

Trilogy Capital’s Portfolio RODM Stock Details RODM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.84M Sell
69,599
-5,026
-7% -$209K 0.11% 143
2026
Q2 		$3.02M Sell
74,625
-232
-0.3% -$9.5K 0.12% 140
2026
Q1 		$2.95M Sell
74,857
-7,723
-9% -$302K 0.13% 127
2025
Q4 		$3.05M Sell
82,580
-4,802
-5% -$174K 0.14% 126
2025
Q3 		$3.1M Sell
87,382
-12,422
-12% -$433K 0.14% 106
2025
Q2 		$3.4M Sell
99,804
-27,746
-22% -$903K 0.17% 87
2025
Q1 		$3.95M Sell
127,550
-528,234
-81% -$15.9M 0.21% 73
2024
Q4 		$18.6M Buy
655,784
+3,489
+0.5% +$103K 0.96% 30
2024
Q3 		$19.9M Sell
652,295
-14,494
-2% -$422K 1% 28
2024
Q2 		$18.4M Sell
666,789
-398,109
-37% -$11.2M 1% 29
2024
Q1 		$29.8M Sell
1,064,898
-70,290
-6% -$1.92M 1.72% 16
2023
Q4 		$31.1M Sell
1,135,188
-99,738
-8% -$2.59M 1.93% 13
2023
Q3 		$31.7M Sell
1,234,926
-34,549
-3% -$910K 2.14% 14
2023
Q2 		$34.3M Sell
1,269,475
-54,066
-4% -$1.45M 2.19% 12
2023
Q1 		$34.8M Buy
1,323,541
+3,165
+0.2% +$82.2K 2.48% 12
2022
Q4 		$32.7M Buy
1,320,376
+99,466
+8% +$2.37M 2.32% 11
2022
Q3 		$26.5M Buy
1,220,910
+34,796
+3% +$852K 2.38% 10
2022
Q2 		$29.5M Buy
1,186,114
+33,030
+3% +$901K 2.57% 10
2022
Q1 		$33.6M Buy
1,153,084
+57,289
+5% +$1.67M 2.41% 11
2021
Q4 		$33M Buy
1,095,795
+30,734
+3% +$933K 2.47% 12
2021
Q3 		$32.1M Sell
1,065,061
-53,160
-5% -$1.65M 2.44% 12
2021
Q2 		$34.7M Sell
1,118,221
-9,183
-0.8% -$285K 2.55% 12
2021
Q1 		$33.5M Buy
1,127,404
+3,519
+0.3% +$102K 2.56% 9
2020
Q4 		$31.8M Buy
1,123,885
+59,367
+6% +$1.61M 2.6% 9
2020
Q3 		$27.6M Buy
1,064,518
+11,191
+1% +$289K 2.63% 9
2020
Q2 		$27M Buy
1,053,327
+1,000
+0.1% +$23.7K 2.67% 10
2020
Q1 		$24.3M Buy
1,052,327
+76,406
+8% +$2.04M 2.69% 11
2019
Q4 		$28.7M Buy
+975,921
New +$28M 2.81% 8

Other funds holding RODM

Goldstein Advisors
Goldstein Advisors Madison, Wisconsin $1.13B AUM 16.75% 1-Year Est. Return
Howard Financial Services
Howard Financial Services Dallas, Texas $954M AUM 13.71% 1-Year Est. Return
First PREMIER Bank
First PREMIER Bank Sioux Falls, South Dakota $621M AUM 13.03% 1-Year Est. Return
FA
Flagstar Advisors New York $330M AUM 30.46% 1-Year Est. Return
FA
Fermata Advisors Sonoma, California $517M AUM 14.47% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Eagle Strategies
Eagle Strategies New York $1.03B AUM 18.98% 1-Year Est. Return
CL
CLG LLC Long Beach, California $481M AUM 21.82% 1-Year Est. Return
WPIC
White Pine Investment Company Livonia, Michigan $480M AUM 15.28% 1-Year Est. Return

Trilogy Capital's RODM Position: Q3 2026 in Review

Trilogy Capital reduced its Hartford Multifactor Developed Markets ex-US ETF (RODM) stake by 6.7% in Q3 2026, selling an estimated $209K and leaving 69,599 shares worth $2.84M. The position accounts for 0.11% of the portfolio, ranked #143.

Trilogy Capital first reported a position in RODM in Q4 2019 and has held it in 28 quarters since. The position peaked at $34.8M in Q1 2023. 23 funds tracked by Wall St. Rank hold RODM as of Q3 2026.

  • Trilogy Capital held 69,599 shares of Hartford Multifactor Developed Markets ex-US ETF worth $2.84M as of Q3 2026.
  • Trilogy Capital sold 5,026 Hartford Multifactor Developed Markets ex-US ETF shares in Q3 2026, an estimated $209K.
  • Hartford Multifactor Developed Markets ex-US ETF made up 0.11% of Trilogy Capital's portfolio in Q3 2026, its #143 holding.
  • Trilogy Capital first reported a position in Hartford Multifactor Developed Markets ex-US ETF in Q4 2019 and has held it in 28 quarters since.
  • Trilogy Capital's Hartford Multifactor Developed Markets ex-US ETF position peaked at $34.8M in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Hartford Multifactor Developed Markets ex-US ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.